Inflammatory proteomics of uterine fluid is potentially a non-invasive predictor for endometrial receptivity: a pilot study
Journal of Assisted Reproduction and Genetics, 2025
Zeng H., Chang Y., Fu J., Tang H., Liu N., Luo B., Li S.
| Disease area | Application area | Sample type | Products |
|---|---|---|---|
Obstetrics | Patient Stratification | Uterine Fluid |  Olink Target 96 |
Abstract
Purpose
To evaluate whether the inflammatory proteomics of uterine fluid is feasible in defining the endometrial receptivity phase.
Methods
Inflammatory proteomics of uterine fluid was measured using the OLINK Target-96 Inflammation panel. Endometrial receptivity testing (ERT) combined with endometrial dating was used to define the phase of endometrial receptivity. A predictive model based on proteomics of uterine fluid was established to predict the endometrial receptivity phase.
Results
The inflammatory factors in uterine fluid were differentially expressed between the window of implantation (WOI) and displaced WOI groups; the displaced WOI group was characterized by increased expression of a variety of inflammatory factors. The predictive model established based on the top five differential proteins could classify the endometrial receptive phase. Transcriptomic data from endometrial tissues showed that the differential gene sets between different receptive phases were mostly enriched in immune-related processes, and the expression of immune-related genes in the WOI group was significantly lower than that in the displaced WOI group.
Conclusions
Detecting inflammatory proteins from the uterine fluid using the OLINK inflammation panel is feasible and holds promise as a novel non-invasive method to define endometrial receptivity phases.